Nicht-interventionelle Studie FalphasT: Schnelle Verbesserung der patientenrelevanten Outcomes (PRO) mit CERTOLIZUMAB PEGOL zur Behandlung der rheumatoiden Arthritis im deutschen Praxisalltag

Authors
Publication date
12 September 2014
Publisher
German Medical Science GMS Publishing House; Düsseldorf
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      German Medical Science

      redirect
      oaioai:oai-gms.dimdi.de:GM14dgrh2...
      Last time updated on 09/07/2019